+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Allergy Immunotherapies Market 2020-2024 - Product Image

Global Allergy Immunotherapies Market 2020-2024

  • ID: 5008937
  • Report
  • March 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Aimmune Therapeutics Inc.
  • ALK-Abelló AS
  • Allergy Therapeutics Plc
  • ASIT Biotech SA
  • DBV Technologies SA
  • HAL Allergy BV
  • MORE
Global Allergy Immunotherapies Market 2020-2024

The publisher has been monitoring the global allergy immunotherapies market and it is poised to grow by USD 626.77 mn during 2020-2024, progressing at a CAGR of 7% during the forecast period. The report on the global allergy immunotherapies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of allergies. In addition, growing popularity of slit is anticipated to boost the growth of the global allergy immunotherapies market as well.

Market Segmentation

This global allergy immunotherapies market is segmented as below:

Product:
  • SCIT
  • SLIT
Geographic Segmentation:
  • APAC
  • Europe
  • MEA
  • North America
  • South America
Key Trends for global allergy immunotherapies market growth

This study identifies growing popularity of slit as the prime reasons driving the global allergy immunotherapies market growth during the next few years.

Prominent vendors in global allergy immunotherapies market

The publisher provides a detailed analysis of around 25 vendors operating in the global allergy immunotherapies market 2020-2024, including some of the vendors such as Aimmune Therapeutics Inc., ALK-Abelló AS, Allergy Therapeutics Plc, ASIT Biotech SA, DBV Technologies SA, HAL Allergy BV, Jubilant Life Sciences Ltd., Laboratorios LETI SLU, Merck KGaA and Stallergenes Greer Plc .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Aimmune Therapeutics Inc.
  • ALK-Abelló AS
  • Allergy Therapeutics Plc
  • ASIT Biotech SA
  • DBV Technologies SA
  • HAL Allergy BV
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Product
  • Market segments
  • Comparison by Product placement
  • SCIT - Market size and forecast 2019-2024
  • SLIT - Market size and forecast 2019-2024
  • Market opportunity by Product
Customer landscape
  • Overview
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • Europe - Market size and forecast 2019-2024
  • North America - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
Drivers, Challenges, and Trends
  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Aimmune Therapeutics Inc.
  • ALK-Abelló AS
  • Allergy Therapeutics Plc
  • ASIT Biotech SA
  • DBV Technologies SA
  • HAL Allergy BV
  • Jubilant Life Sciences Ltd.
  • Laboratorios LETI SLU
  • Merck KGaA
  • Stallergenes Greer Plc
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1. Key Finding 1
2. Key Finding 2
3. Key Finding 3
4. Key Finding 5
5. Key Finding 6
6. Key Finding 7
7. Key Finding 8
8. Market in focus
9. Parent market
10. Market characteristics
11. Product / Service portfolio of key vendors included in the market definition
12. Market segments
13. Global - Market size and forecast 2019 - 2024 ($ million)
14. Global market: Year-over-year growth 2019 - 2024 (%)
15. Five forces analysis 2019 & 2024
16. Bargaining power of buyers
17. Bargaining power of suppliers
18. Threat of new entrants
19. Threat of substitutes
20. Threat of rivalry
21. Market condition - Five forces 2019
22. Product placement - Market share 2019-2024 (%)
23. Comparison by Product placement
24. SCIT - Market size and forecast 2019-2024 ($ million)
25. SCIT - Year-over-year growth 2019-2024 (%)
26. SLIT - Market size and forecast 2019-2024 ($ million)
27. SLIT - Year-over-year growth 2019-2024 (%)
28. Market opportunity by Product
29. Customer landscape
30. Market share by geography 2019-2024 (%)
31. Geographic comparison
32. Europe - Market size and forecast 2019-2024 ($ million)
33. Europe - Year-over-year growth 2019-2024 (%)
34. North America - Market size and forecast 2019-2024 ($ million)
35. North America - Year-over-year growth 2019-2024 (%)
36. APAC - Market size and forecast 2019-2024 ($ million)
37. APAC - Year-over-year growth 2019-2024 (%)
38. MEA - Market size and forecast 2019-2024 ($ million)
39. MEA - Year-over-year growth 2019-2024 (%)
40. South America - Market size and forecast 2019-2024 ($ million)
41. South America - Year-over-year growth 2019-2024 (%)
42. Key leading countries
43. Market opportunity by geography ($ million)
44. Impact of drivers and challenges
45. Vendor landscape
46. Landscape disruption
47. Industry risks
48. Vendors covered
49. Market positioning of vendors
50. Aimmune Therapeutics Inc. - Overview
51. Aimmune Therapeutics Inc. - Business segments
52. Aimmune Therapeutics Inc. - Key offerings
53. Aimmune Therapeutics Inc. - Key customers
54. Aimmune Therapeutics Inc. - Segment focus
55. ALK-Abelló AS - Overview
56. ALK-Abelló AS - Product and service
57. ALK-Abelló AS - Key offerings
58. ALK-Abelló AS - Key customers
59. ALK-Abelló AS - Segment focus
60. Allergy Therapeutics Plc - Overview
61. Allergy Therapeutics Plc - Business segments
62. Allergy Therapeutics Plc - Key offerings
63. Allergy Therapeutics Plc - Key customers
64. Allergy Therapeutics Plc - Segment focus
65. ASIT Biotech SA - Overview
66. ASIT Biotech SA - Business segments
67. ASIT Biotech SA - Key offerings
68. ASIT Biotech SA - Key customers
69. ASIT Biotech SA - Segment focus
70. DBV Technologies SA - Overview
71. DBV Technologies SA - Business segments
72. DBV Technologies SA - Key offerings
73. DBV Technologies SA - Key customers
74. DBV Technologies SA - Segment focus
75. HAL Allergy BV - Overview
76. HAL Allergy BV - Business segments
77. HAL Allergy BV - Key offerings
78. HAL Allergy BV - Key customers
79. HAL Allergy BV - Segment focus
80. Jubilant Life Sciences Ltd. - Overview
81. Jubilant Life Sciences Ltd. - Business segments
82. Jubilant Life Sciences Ltd. - Key offerings
83. Jubilant Life Sciences Ltd. - Key customers
84. Jubilant Life Sciences Ltd. - Segment focus
85. Laboratorios LETI SLU - Overview
86. Laboratorios LETI SLU - Business segments
87. Laboratorios LETI SLU - Key offerings
88. Laboratorios LETI SLU - Key customers
89. Laboratorios LETI SLU - Segment focus
90. Merck KGaA - Overview
91. Merck KGaA - Business segments
92. Merck KGaA - Key offerings
93. Merck KGaA - Key customers
94. Merck KGaA - Segment focus
95. Stallergenes Greer Plc - Overview
96. Stallergenes Greer Plc - Product and service
97. Stallergenes Greer Plc - Key offerings
98. Stallergenes Greer Plc - Key customers
99. Stallergenes Greer Plc - Segment focus
100. Currency conversion rates for US$
101. Research Methodology
102. Validation techniques employed for market sizing
103. Information sources
104. List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Aimmune Therapeutics Inc.
  • ALK-Abelló AS
  • Allergy Therapeutics Plc
  • ASIT Biotech SA
  • DBV Technologies SA
  • HAL Allergy BV
  • MORE
The publisher recognizes the following companies as the key players in the global allergy immunotherapies market 2020-2024: Aimmune Therapeutics Inc., ALK-Abelló AS, Allergy Therapeutics Plc, ASIT Biotech SA, DBV Technologies SA, HAL Allergy BV, Jubilant Life Sciences Ltd., Laboratorios LETI SLU, Merck KGaA and Stallergenes Greer Plc.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the growing popularity of slit."

According to the report, one of the major drivers for this market is the increasing prevalence of allergies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • Aimmune Therapeutics Inc.
  • ALK-Abelló AS
  • Allergy Therapeutics Plc
  • ASIT Biotech SA
  • DBV Technologies SA
  • HAL Allergy BV
  • Jubilant Life Sciences Ltd.
  • Laboratorios LETI SLU
  • Merck KGaA
  • Stallergenes Greer Plc
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll